These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 26619075)
1. Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations. Samanta PN; Das KK J Mol Graph Model; 2016 Jan; 63():38-48. PubMed ID: 26619075 [TBL] [Abstract][Full Text] [Related]
2. Binding affinity of substituted ureido-benzenesulfonamide ligands to the carbonic anhydrase receptor: a theoretical study of enzyme inhibition. Sahu C; Sen K; Pakhira S; Mondal B; Das AK J Comput Chem; 2013 Aug; 34(22):1907-16. PubMed ID: 23712937 [TBL] [Abstract][Full Text] [Related]
3. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies. Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic investigation of sulfonamide ligands as human carbonic anhydrase II inhibitors. Alaei L; Khodarahmi R; Sheikh-Hasani V; Sheibani N; Moosavi-Movahedi AA Int J Biol Macromol; 2018 Dec; 120(Pt A):1198-1207. PubMed ID: 30176324 [TBL] [Abstract][Full Text] [Related]
6. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. Pacchiano F; Aggarwal M; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT Chem Commun (Camb); 2010 Nov; 46(44):8371-3. PubMed ID: 20922253 [TBL] [Abstract][Full Text] [Related]
7. Spectroscopic and molecular modeling studies on binding of dorzolamide to bovine and human carbonic anhydrase II. Bijari N; Ghobadi S; Mahdiuni H; Khodarahmi R; Ghadami SA Int J Biol Macromol; 2015 Sep; 80():189-99. PubMed ID: 26093313 [TBL] [Abstract][Full Text] [Related]
8. Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors. Poli G; Jha V; Martinelli A; Supuran CT; Tuccinardi T Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937490 [TBL] [Abstract][Full Text] [Related]
9. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of the binding modes of SLC-0111 and its analogues in the hCA II and hCA IX active sites using QM/MM, molecular docking, MM-GBSA and MD approaches. Chahal V; Nirwan S; Kakkar R Biophys Chem; 2020 Oct; 265():106439. PubMed ID: 32738591 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Temperini C; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives. Fidan İ; Salmas RE; Arslan M; Şentürk M; Durdagi S; Ekinci D; Şentürk E; Coşgun S; Supuran CT Bioorg Med Chem; 2015 Dec; 23(23):7353-8. PubMed ID: 26534780 [TBL] [Abstract][Full Text] [Related]
13. QM/MM calculations reveal the different nature of the interaction of two carborane-based sulfamide inhibitors of human carbonic anhydrase II. Pecina A; Lepšík M; Řezáč J; Brynda J; Mader P; Řezáčová P; Hobza P; Fanfrlík J J Phys Chem B; 2013 Dec; 117(50):16096-104. PubMed ID: 24289143 [TBL] [Abstract][Full Text] [Related]
14. Phosphorus versus Sulfur: Discovery of Benzenephosphonamidates as Versatile Sulfonamide-Mimic Chemotypes Acting as Carbonic Anhydrase Inhibitors. Nocentini A; Gratteri P; Supuran CT Chemistry; 2019 Jan; 25(5):1188-1192. PubMed ID: 30411821 [TBL] [Abstract][Full Text] [Related]
15. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamide-two heads are better than one? Casini A; Abbate F; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2003 Aug; 13(16):2759-63. PubMed ID: 12873509 [TBL] [Abstract][Full Text] [Related]
18. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII. Saluja AK; Tiwari M; Vullo D; Supuran CT Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918 [TBL] [Abstract][Full Text] [Related]
19. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations. Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]